Results 21 to 30 of about 86,432 (312)

Subcutaneous Implantable Cardioverter-Defibrillator [PDF]

Circulation, 2014
For nearly 3 decades, the implantable cardioverter-defibrillator (ICD) has been available to patients who survived life-threatening rapid heart rhythms or are at risk of experiencing them. The ICD comprises a device generator coupled with a defibrillation lead.
Philip M, Chang, Rahul, Doshi, Leslie A, Saxon   +2 more
openaire   +2 more sources

Cardiac Magnetic Resonance Imaging–Derived Left Atrial Characteristics in Relation to Atrial Fibrillation Detection in Patients With an Implantable Cardioverter‐Defibrillator

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Among patients with an implantable cardioverter‐defibrillator, a high prevalence of atrial fibrillation (AF) is present. Identification of AF predictors in this patient group is of clinical importance to initiate appropriate preventive ...
Luuk H. G. A. Hopman, Anne‐Lotte C. J. van der Lingen, Nikki van Pouderoijen, Judith Krabbenborg, Mark J. Mulder, Mischa T. Rijnierse, Pranav Bhagirath, Lourens F. H. J. Robbers, Albert C. van Rossum, Vokko P. van Halm, Marco J. W. Götte, Cornelis P. Allaart   +11 more
doaj   +1 more source

Irradiation treatment of laryngeal cancer in a patient with an implantable cardioverter-defibrillator (ICD) [PDF]

, 2007
Background: Due to an aging population the incidence of both cardiac and tumor-related illnesses is increasing. A problem may arise if radiotherapy is necessary in close anatomic proximity to an implantable cardioverter-defibrillator (ICD).
Krimmel, Klaus, Schaffer, Moshe, Schaffer, Pamela Manuela, Sepe, Susanna   +3 more
core   +1 more source

Patient perceptions of implantable cardioverter-defibrillator deactivation discussions: A qualitative study

SAGE Open Medicine, 2016
Background: There is a class I recommendation for implantable cardioverter-defibrillator deactivation discussions to occur between physicians and heart failure patients.
Jane MacIver, Alana Tibbles, Filio Billia, Heather Ross   +3 more
doaj   +1 more source

Effects of sacubitril/valsartan in the PARADIGM-HF Trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure) according to background therapy [PDF]

, 2016
Background—In the PARADIGM-HF trial (Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure), the angiotensin receptor neprilysin inhibitor sacubitril/valsartan was more effective than the ...
Gong, Jianjian, Jhund, Pardeep S., Lefkowitz, Martin P., McMurray, John J.V., Okumura, Naoki, Packer, Milton, Rizkala, Adel R., Rouleau, Jean L., Shi, Victor C., Solomon, Scott D., Swedberg, Karl, Zile, Michael R.   +11 more
core   +2 more sources

2019 HRS/EHRA/APHRS/LAHRS focused update to 2015 expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Europace, 2019
The 2015 HRS/EHRA/APHRS/SOLAECE Expert Consensus Statement on Optimal Implantable Cardioverter-Defibrillator Programming and Testing provided guidance on bradycardia programming, tachycardia detection, tachycardia therapy, and defibrillation testing for ...
M. Stiles, L. Fauchier, C. Morillo, B. Wilkoff   +3 more
semanticscholar   +1 more source

EuroEco (European Health Economic Trial on Home Monitoring in ICD Patients): a provider perspective in five European countries on costs and net financial impact of follow-up with or without remote monitoring [PDF]

, 2014
Aim: Remote follow-up (FU) of implantable cardiac defibrillators (ICDs) allows for fewer in-office visits in combination with earlier detection of relevant findings. Its implementation requires investment and reorganization of care. Providers (physicians
Annemans, Lieven, Beeton, Ian, Broadhurst, Paul, Cross, Stephen, Fernandez-Lozano, Ignacio, Garcia, Enrique, Heidbuchel, Hein, Hindricks, Gerd, Koivisto, Ulla-Maija, Löscher, Steffen, Malinowski, Klaus, Marek, Andrea, Peinado, Rafael, Rivero-Ayerza, Maximo, Romero Garrido, Rafael F, Smala, Antje, Van Erven, Lieselot, Vijgen, Johan   +17 more
core   +3 more sources

Selecting patients with nonischemic dilated cardiomyopathy for ICDs [PDF]

, 2017
No abstract ...
Cleland, John G.F., Halliday, Brian P., Prasad, Sanjay K.   +2 more
core   +1 more source

Assessment of the 2017 AHA/ACC/HRS Guideline Recommendations for Implantable Cardioverter-Defibrillator Implantation in Cardiac Sarcoidosis.

Circulation: Arrhythmia and Electrophysiology, 2019
BACKGROUND Implantable cardioverter-defibrillators are used to prevent sudden cardiac death in patients with cardiac sarcoidosis. The most recent recommendations for implantable cardioverter-defibrillator implantation in these patients are in the 2017 ...
Felipe Kazmirczak, K. Chen, S. Adabag, Lisa von Wald, H. Roukoz, D. Benditt, O. Okasha, A. Farzaneh-Far, J. Markowitz, P. Nijjar, P. Velangi, M. Bhargava, D. Perlman, S. Duval, M. Akçakaya, C. Shenoy   +15 more
semanticscholar   +1 more source

Implant and Midterm Outcomes of the Subcutaneous Implantable Cardioverter-Defibrillator Registry: The EFFORTLESS Study.

Journal of the American College of Cardiology, 2017
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to defibrillate ventricular arrhythmias, avoiding drawbacks of transvenous leads.
L. Boersma, C. Barr, R. Knops, D. Theuns, L. Eckardt, P. Neužil, M. Scholten, M. Hood, J. Kuschyk, P. Jones, E. Duffy, M. Husby, K. Stein, P. Lambiase   +13 more
semanticscholar   +1 more source